SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

50,945.10 -425.82
(-0.83%)

Dow Jones

7,674.56 -17.28
(-0.22%)

Hang Seng

68,949.71 2,195.99
(3.29%)

Nikkei 225

10,610.72 -25.99
(-0.24%)

Forex

USD-INR

95.97 0.01
(0.01%)

EUR-INR

108.89 -0.26
(-0.24%)

GBP-INR

126.98 -0.19
(-0.15%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Oxygenta Pharmaceutical reports standalone net loss of Rs 2.10 crore in the June 2026 quarter

Jul 28,2026

Net Loss of Oxygenta Pharmaceutical reported to Rs 2.10 crore in the quarter ended June 2026 as against net loss of Rs 6.11 crore during the previous quarter ended June 2025. Sales rose 144.55% to Rs 37.00 crore in the quarter ended June 2026 as against Rs 15.13 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	37.00	15.13	145
OPM %	1.51	-45.14	-
PBDT	-1.88	-7.29	74
PBT	-2.50	-8.14	69
NP	-2.10	-6.11	66

71,909.70 -570.59 ( -0.79%)

50,945.10 -425.82 (-0.83%)

7,674.56 -17.28 (-0.22%)

68,949.71 2,195.99 (3.29%)

10,610.72 -25.99 (-0.24%)

95.97 0.01 (0.01%)

108.89 -0.26 (-0.24%)

126.98 -0.19 (-0.15%)

0.61 0.00 (0.01%)